For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $3.19 in the prior trading day, Arbutus Biopharma Corp (NASDAQ: ABUS) closed at $3.16, down -0.94%. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 0.8 million shares were traded. ABUS stock price reached its highest trading level at $3.23 during the session, while it also had its lowest trading level at $3.14.
Ratios:
Our goal is to gain a better understanding of ABUS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.15 and its Current Ratio is at 6.01. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 25, 2021, Jefferies started tracking the stock assigning a Hold rating and target price of $5.
On December 17, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on December 17, 2020, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 21 ’25 when McElhaugh Michael J. bought 246,886 shares for $3.26 per share.
McElhaugh Michael J. bought 53,114 shares of ABUS for $170,098 on Apr 15 ’25. On Mar 31 ’25, another insider, Sofia Michael J., who serves as the Officer of the company, bought 250,000 shares for $3.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABUS now has a Market Capitalization of 605076800 and an Enterprise Value of 495525376. For the stock, the TTM Price-to-Sale (P/S) ratio is 98.07 while its Price-to-Book (P/B) ratio in mrq is 7.64. Its current Enterprise Value per Revenue stands at 77.39 whereas that against EBITDA is -7.489.
Stock Price History:
The Beta on a monthly basis for ABUS is 1.22, which has changed by 0.09342563 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, ABUS has reached a high of $4.72, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -4.06%, while the 200-Day Moving Average is calculated to be -11.61%.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 872770 shares per day over the last 10 days, according to various share statistics. A total of 191.50M shares are outstanding, with a floating share count of 148.63M. Insiders hold about 22.38% of the company’s shares, while institutions hold 55.45% stake in the company. Shares short for ABUS as of 1745971200 were 11190235 with a Short Ratio of 10.49, compared to 1743379200 on 9847908. Therefore, it implies a Short% of Shares Outstanding of 11190235 and a Short% of Float of 8.3000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
